366 related articles for article (PubMed ID: 16389181)
1. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
Rothman N; Skibola CF; Wang SS; Morgan G; Lan Q; Smith MT; Spinelli JJ; Willett E; De Sanjose S; Cocco P; Berndt SI; Brennan P; Brooks-Wilson A; Wacholder S; Becker N; Hartge P; Zheng T; Roman E; Holly EA; Boffetta P; Armstrong B; Cozen W; Linet M; Bosch FX; Ennas MG; Holford TR; Gallagher RP; Rollinson S; Bracci PM; Cerhan JR; Whitby D; Moore PS; Leaderer B; Lai A; Spink C; Davis S; Bosch R; Scarpa A; Zhang Y; Severson RK; Yeager M; Chanock S; Nieters A
Lancet Oncol; 2006 Jan; 7(1):27-38. PubMed ID: 16389181
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
[TBL] [Abstract][Full Text] [Related]
3. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.
Kane E; Skibola CF; Bracci PM; Cerhan JR; Costas L; Smedby KE; Holly EA; Maynadié M; Novak AJ; Lightfoot TJ; Ansell SM; Smith AG; Liebow M; Melbye M; Morton L; de Sanjosé S; Slager SL; Wang SS; Zhang Y; Zheng T; Roman E
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1061-70. PubMed ID: 25962811
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
Ennas MG; Moore PS; Zucca M; Angelucci E; Cabras MG; Melis M; Gabbas A; Serpe R; Madeddu C; Scarpa A; Cocco P
Hematol Oncol; 2008 Jun; 26(2):98-103. PubMed ID: 18271063
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.
Du GH; Wang JK; Richards JR; Wang JJ
Int Immunopharmacol; 2019 Jan; 66():154-161. PubMed ID: 30453149
[TBL] [Abstract][Full Text] [Related]
10. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
11. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
[TBL] [Abstract][Full Text] [Related]
12. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations.
Hosgood HD; Au WY; Kim HN; Liu J; Hu W; Tse J; Song B; Wong KF; Lee JJ; Chanock SJ; Siu LP; Purdue MP; Shin MH; Yu J; Liang R; Kim HJ; Rothman N; Lan Q
Int J Hematol; 2013 Jun; 97(6):793-9. PubMed ID: 23640160
[TBL] [Abstract][Full Text] [Related]
13. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
14. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
Ye X; Zhao K; Wu C; Hu P; Fu H
Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ
Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825
[TBL] [Abstract][Full Text] [Related]
16. Association between TNF, IL1B, IL6, IL10 and IFNG polymorphisms and recurrent miscarriage: a case control study.
Ma J; Zhang X; He G; Yang C
Reprod Biol Endocrinol; 2017 Oct; 15(1):83. PubMed ID: 29017513
[TBL] [Abstract][Full Text] [Related]
17. Association between non-Hodgkin lymphoma and haplotypes in the TNF region.
Spink CF; Keen LJ; Mensah FK; Law GR; Bidwell JL; Morgan GJ
Br J Haematol; 2006 May; 133(3):293-300. PubMed ID: 16643431
[TBL] [Abstract][Full Text] [Related]
18. Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.
Zhang Y; Xia ZG; Zhu JH; Chen MB; Wang TM; Shen WX; He J
Mol Genet Genomics; 2015 Dec; 290(6):2063-73. PubMed ID: 25977148
[TBL] [Abstract][Full Text] [Related]
19. Interest of tumor necrosis factor-alpha -308 G/A and interleukin-10 -592 C/A polymorphisms in human African trypanosomiasis.
Courtin D; Argiro L; Jamonneau V; N'dri L; N'guessan P; Abel L; Dessein A; Cot M; Laveissiere C; Garcia A
Infect Genet Evol; 2006 Mar; 6(2):123-9. PubMed ID: 15894515
[TBL] [Abstract][Full Text] [Related]
20. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
Mattuzzi S; Barbi S; Carletto A; Ravagnani V; Moore PS; Bambara LM; Scarpa A
J Rheumatol; 2007 May; 34(5):997-1004. PubMed ID: 17444587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
